October 11, 2006, Carlsbad, CA - Next Pharmaceuticals announced today that entirely new delivery systems are now available for Relora®, the block-buster patented blend of ingredients that has been proven in clinical trials to help with anxiety and stress relief. Formulated by a licensed pharmacist, the Next Experience of Relora® will now be available in individual powder paks, effervescent powders, and effervescent tablets that can be dissolved in liquid drinks.
“We’re very excited about offering Relora® in these new powder formula applications for beverages.” said Bob Garrison, CEO of Next Pharmaceuticals. “Next has been well aware of the demand from consumers for more convenient and efficient delivery systems for natural products and this development is proof that we are listening to what the market is telling us and in turn, to what sells.”
Attendees at SupplySide West can pick up samples at Booth # 7047.
Relora® is a natural stress and anxiety management ingredient that also helps control stress-related eating and has the added value of being non-sedating. Relora® is a natural proprietary blend of a patented extract of Magnolia officinalis and a proprietary extract of Phellodendron amurense. This patented blend is the result of screening more than fifty plant fractions from traditional plant medicines used around the world. In a recent open label clinical study on more than a thousand women who reported stress and anxiety, 90% of them reported that Relora® helped in stress relief.
About Next Pharmaceuticals
Next Pharmaceuticals, Inc. (NPI) was founded in 1997 with the purpose of developing new, patented, natural ingredients for healthy living products in the dietary supplement, food and beverage industries. NPI has successfully developed seven patented plant extracts that have significantly expanded the choices for self-care products while providing large consumer brands with powerful product differentiation. Through the application of pharmaceutical technologies to natural botanical materials, including citrus fruits, NPI has developed Relora® for relaxation and stress-related appetite control, Nexrutine® for inflammation, Seditol® for better quality of sleep, and Citri-Z® for heart health. Three new patented ingredients clinically proven to have significant benefits in heart health, inflammation/pain, and insulin function are available for licensing to qualified companies. For more information, please go to http://www.nextpharmaceuticals.com or stop by booth #7047 at Supply Side West.